IP Verse

Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby - EP2825555B1

PatentPatent Analysis

EP2825555

OCTAPHARMA
Application Number
EP13709190A
Filing Date
Mar 12, 2013
Status
Revoked
Dec 6, 2023
Grant Date
Jul 12, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3626737B1
EP2707387B1
EP2640413B1

Bibliography

The patent EP2825555B1 was granted to Octapharma on Jul 12, 2017 following the initial filing on Mar 12, 2013 under the application number EP13709190A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTApr 12, 2018 -
STRAWMANApr 9, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents